Department of Surgery, The University of Hong Kong, Hong Kong, China.
Ann Surg. 2013 Mar;257(3):506-11. doi: 10.1097/SLA.0b013e31827b947a.
Laparoscopic liver resection has been reported as a safe and effective approach to the management of liver cancer. However, studies of long-term outcomes regarding tumor recurrence and patient survival in comparison with the conventional open approach are limited. The aim of this study was to analyze the survival outcome of laparoscopic liver resection versus open liver resection.
Between October 2002 and September 2009, 32 patients underwent pure laparoscopic liver resection for hepatocellular carcinoma (HCC). Case-matched control patients (n = 64) who received open liver resection for HCC were included for comparison. Patients were matched in terms of cancer stage, tumor size, location of tumor, and magnitude of resection. Immediate operation outcomes, operation morbidity, disease-free survival, and overall survival were compared between groups.
With the laparoscopic group compared with the open resection group, operation time was 232.5 minutes versus 204.5 minutes (P = 0.938), blood loss was 150 mL versus 300 mL (P = 0.001), hospital stay was 4 days versus 7 days (P < 0.0001), postoperative complication was 2 (6.3%) versus 12 (18.8%) (P = 0.184), disease-free survival was 78.5 months versus 29 months (P = 0.086), and overall survival was 92 months versus 71 months (P = 0.142). The disease-free survival for stage II HCC was 22.1 months versus 12.4 months (P = 0.075).
Laparoscopic liver resection for HCC is associated with less blood loss, shorter hospital stay, and fewer postoperative complications in selected patients with no compromise in survival.
腹腔镜肝切除术已被报道为一种安全有效的肝癌治疗方法。然而,与传统的开腹手术相比,关于肿瘤复发和患者生存的长期结果的研究有限。本研究旨在分析腹腔镜肝切除术与开腹肝切除术的生存结果。
2002 年 10 月至 2009 年 9 月,32 例肝细胞癌(HCC)患者接受了纯腹腔镜肝切除术。为了进行比较,纳入了 64 例接受开腹肝切除术治疗 HCC 的病例匹配对照患者。根据癌症分期、肿瘤大小、肿瘤位置和切除程度对患者进行匹配。比较两组患者的即刻手术结果、手术发病率、无病生存率和总生存率。
与开腹组相比,腹腔镜组的手术时间为 232.5 分钟对 204.5 分钟(P = 0.938),出血量为 150 毫升对 300 毫升(P = 0.001),住院时间为 4 天对 7 天(P < 0.0001),术后并发症为 2(6.3%)对 12(18.8%)(P = 0.184),无病生存率为 78.5 个月对 29 个月(P = 0.086),总生存率为 92 个月对 71 个月(P = 0.142)。对于 II 期 HCC,无病生存率为 22.1 个月对 12.4 个月(P = 0.075)。
在选择的患者中,腹腔镜肝切除术治疗 HCC 具有出血量少、住院时间短、术后并发症少的优点,而不会影响生存。